Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks

8. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders In Q3 2024: 70

Bristol-Myers Squibb Company (NYSE:BMY) is a healthcare and pharmaceutical firm that is one of Cramer’s favorite stocks because of its schizophrenia medicine. The firm’s Cobenfy drug for schizophrenia is the first of its kind in decades. Bristol-Myers Squibb Company (NYSE:BMY)’s shares have gained 24% over the past year as they have benefited from other catalysts as well such as the FDA’s approval of its cancer drug Opdivo. Cramer’s comments, as expected, surrounded Bristol-Myers Squibb Company (NYSE:BMY)’s Cobenfy drug:

“I mean, look, my charitable trust owns Bristol-Myers, I think Bristol-Myers is [inaudible]. They’ve got a new drug, uh Cobenfy. Yeah Cobenfy which is about schizophrenia, first new drug in thirty years.”